Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Sep 29, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹37.751+0.17% 1 day change | 20.1% p.a. | App exclusive | ₹2,796 Cr |
AUM (Fund size) | ₹2,796 Cr |
Exit load | 1.0% Exit load of 1% if redeemed within 1 year.! |
Lock-in Period | Nil |
Age | 7 yrs 3 m since Jun 11, 2018 |
Benchmark | BSE Healthcare TRI |
Min. investment | This scheme is currently not buyable |
Expense ratio | 1.93% as on Aug 31, 2025 |
Plan type | Regular |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Period | This fund | Category average |
---|---|---|
1 Month | -0.99% | -1.58% |
3 Months | -1.04% | -2.06% |
6 Months | 3.4% | 4.18% |
1 Year | -3.37% | -2.96% |
2 Years | 20.72% | 21.59% |
3 Years | 19.92% | 22.12% |
4 Years | 12.34% | 13.29% |
5 Years | 16.8% | 16.81% |
7 Years | 19.77% | 18.92% |
Large Cap 45.26%
Mid Cap 27.61%
Small Cap 26.72%
Other Cap 0%
Healthcare 97.47000000000001%
Chemicals 1.31%
Services 0.83%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Repo 0.82657229%
Mutual Fund 0.00820267%
Others 0.83%
Mirae Asset Liquid Fund Direct- Growth 0.01%
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
Mirae Asset Healthcare Fund | -0.99% | 3.4% | -3.37% | 19.92% | 16.8% | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | -1.59% | 7.82% | 0.05% | 26.79% | 19.52% | 14.7% |
SBI Healthcare Opportunities Fund | -1.82% | 2.09% | 0.02% | 24.46% | 18.75% | 10.81% |
DSP Healthcare Fund | -1.82% | 2.44% | -6.15% | 22.13% | 16.86% | 14.31% |
Tata India Pharma & Healthcare Fund | -1.38% | 4.72% | -3.75% | 21.66% | 17.13% | 11.57% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
Mirae Asset Healthcare Fund | 16.36 | 1.0 | 0.86 | 1.36 |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.51 | 0.94 | 1.27 | 1.79 |
SBI Healthcare Opportunities Fund | 13.91 | 0.84 | 1.29 | 1.93 |
DSP Healthcare Fund | 14.57 | 0.84 | 1.14 | 1.87 |
Tata India Pharma & Healthcare Fund | 15.94 | 0.97 | 1.0 | 1.54 |
Fund name | ETM Rank | AUM | Fund age | Expense ratio |
---|---|---|---|---|
Mirae Asset Healthcare Fund | N.A. | 2,796 Cr | 7 yrs 3 m | 1.93% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,162 Cr | 7 yrs 3 m | 1.88% |
SBI Healthcare Opportunities Fund | N.A. | 3,963 Cr | 26 yrs 3 m | 1.93% |
DSP Healthcare Fund | N.A. | 2,961 Cr | 6 yrs 10 m | 1.93% |
Tata India Pharma & Healthcare Fund | N.A. | 1,232 Cr | 9 yrs 9 m | 2.1% |
Alpha | -2.88 vs. 5.81 Underperformed at beating benchmark |
Sharpe | 0.86 vs. 3.71 Poor risk-adjusted returns |
Beta | 1.0 vs. 0.71 More sensitive to market's ups & downs |
Standard deviation | 16.36 vs. 9.06 More volatile performance |
Fund AUM | 2,796 Cr as on Aug 31, 2025 |
Scheme document | View Scheme Document |
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
No. of schemes | 47 view all schemes |
Total AUM | 2,02,662 Cr as on Jun 30, 2025 |
Address | Unit No.606 - 6th Floor, Windsor Building - Off. CST Road, Kalina, Santacruz (East), Mumbai, 400098 |
Phone | 022-67800301 / 1800-2090-777 |
Fund name | ETM Rank | AUM | 1Y | 5Y |
---|---|---|---|---|
Mirae Asset Midcap Fund | N.A. | 16,807 Cr | -3.9% | 25.89% |
Mirae Asset Great Consumer Fund | N.A. | 4,552 Cr | -8.22% | 21.72% |
Mirae Asset Large & Midcap Fund | N.A. | 40,020 Cr | -4.5% | 20.74% |
Mirae Asset ELSS Tax Saver Fund | N.A. | 25,562 Cr | -2.77% | 20.62% |
Mirae Asset Large Cap Fund | N.A. | 39,477 Cr | -3.32% | 16.75% |
The current Net Asset Value (NAV) of the Mirae Asset Healthcare Fund plan is approximately ₹37.751 as of Sep 29, 2025.
The Mirae Asset Healthcare Fund is a 7 yrs 3 m old fund and has delivered average annual returns of 20.1% since inception.
1-Year | 3-Year | 5-Year | Since Inception |
---|---|---|---|
-3.37% | 19.92% | 16.8% | 20.1% |
The Mirae Asset Healthcare Fund has an expense ratio of 1.93%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The Mirae Asset Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 2,796 Cr as on Aug 31, 2025.
The Mirae Asset Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Sun Pharmaceutical Industries Ltd. | 10.92% |
Divi's Laboratories Ltd. | 8.15% |
Glenmark Pharmaceuticals Ltd. | 6.79% |
Apollo Hospitals Enterprise Ltd. | 6.32% |
Cipla Ltd. | 6.3% |
Aurobindo Pharma Ltd. | 6.02% |
Lupin Ltd. | 4.94% |
Dr. Reddy's Laboratories Ltd. | 4.27% |
Fortis Healthcare Ltd. | 3.89% |
Krishna Institute of Medical Sciences Ltd | 3.82% |
The Mirae Asset Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 97.47000000000001% |
Chemicals | 1.31% |
Services | 0.83% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the Mirae Asset Healthcare Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.